Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1998

Study Completion Date

September 30, 2000

Conditions
Pulmonary Hypertension
Interventions
DRUG

UT-15

Trial Locations (7)

10032

Columbia University College of Physicians and Surgeons, New York

21201

University of Maryland Medical System, Baltimore

27709

United Therapeutics Corporation, Research Triangle Park

55905

Mayo Clinic, Rochester

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

90509

Los Angeles County Harbor-UCLA Medical Center, Torrance

37232-2516

Vanderbilt University Medical Center, Nashville

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY